CHMP5 and acute lymphoblastic leukemia: CHMP5 depletion had no impact on T-ALL cell viability (Figure S1B), but EdU (5-ethynyl-2’-deoxyuridine) incorporation indicated a proliferation defect in KD cells which appeared arrested at S phase with impaired G2/M progression (Figure S1C).